FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More nonsmokers are getting lung cancer: Oncologist explains why

2.

FDA Approves CAR-T Product Use for Myeloma Early.

3.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

4.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

5.

ALK-positive lung cancer trial results show unprecedented progression-free survival.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot